Journal article

PROTECTION AGAINST LETHAL LYMPHOCYTIC CHORIOMENINGITIS VIRUS (LCMV) INFECTION BY IMMUNIZATION OF MICE WITH AN INFLUENZA-VIRUS CONTAINING AN LCMV EPITOPE RECOGNIZED BY CYTOTOXIC T-LYMPHOCYTES

MR CASTRUCCI, S HOU, PC DOHERTY, Y KAWAOKA

Journal of Virology | AMER SOC MICROBIOLOGY | Published : 1994

Abstract

The reverse genetics system has made it possible to modify the influenza virus genome. By this method, we were able to assess influenza virus as a vaccine vector for protecting BALB/c mice against otherwise lethal lymphocytic choriomeningitis virus (LCMV) infection. A single dose of influenza virus [A/WSN/33 (H1N1)] bearing a cytotoxic T-lymphocyte-specific epitope of the LCMV nucleoprotein (residues 116 to 127) in the neuraminidase stalk protected mice against LCMV challenge for at least 4 months. The immunity was mediated by cytotoxic T lymphocytes and was haplotype specific, indicating that the observed protective response was solely a consequence of prior priming with the H-2d LCMV nucle..

View full abstract

University of Melbourne Researchers